Photodynamic Therapy for Esophageal Cancer
Author Information
Author(s): JAMES S. McCAUGHAN, JR.
Primary Institution: Grant Medical Center
Hypothesis
What factors affect survival rates and complications in patients with obstructive esophageal cancer treated with photodynamic therapy?
Conclusion
Photodynamic therapy for esophageal carcinoma resulted in minimal complications and improved survival compared to historical treatment regimens.
Supporting Evidence
- The median survival after PDT for all patients was 6.5 months.
- Stage I patients had a median survival of 56 months, while Stage IV patients had 3.5 months.
- Karnofsky Performance Status was a significant factor affecting survival in Stages III and IV.
Takeaway
Doctors used a special light treatment to help patients with blocked esophagus due to cancer, and it worked pretty well with few side effects.
Methodology
The study treated 140 patients with obstructive esophageal cancer using photodynamic therapy and evaluated their survival rates.
Limitations
The study only included patients who had failed or were ineligible for other treatments.
Participant Demographics
Patients aged 35 to 91, with a mean age of 68; included 95 with adenocarcinoma and 45 with squamous carcinoma.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Want to read the original?
Access the complete publication on the publisher's website